Gerresheimer has announced a $180 million, 194,000 sq ft expansion of its device manufacturing facilities near Atlanta, GA, USA. The company says that the expansion will create more than 400 new jobs at its Georgia facilities, where it manufactures medical devices including inhalers, bringing its total workforce in Georgia to almost 700. According to Gerresheimer, … [Read more...] about Gerresheimer adds capacity for inhaler manufacturing at US facility
Products and Services
Cleveland Clinic to perform additional preclinical testing of dry powder universal flu vaccine candidates formulated with TFF technology
TFF Pharmaceuticals announced the Cleveland Clinic Florida will perform additional preclinical studies of 3 dry powder hemagglutinin antigen/adjuvent vaccine candidates produced under a 2023 SBIR grant to TFF for preclinical development of a dry powder pan-influenza vaccine formulation for inhaled and/or nasal delivery. The vaccine developed in Ted Ross's lab at the … [Read more...] about Cleveland Clinic to perform additional preclinical testing of dry powder universal flu vaccine candidates formulated with TFF technology
Renaissance Lakewood opens new headquarters
CDMO Renaissance Lakewood, which offers a wide range of nasal spray development and manufacturing services, announced the official opening of its new offices and warehouse space in Lakewood, NJ, USA. According to the company, the new 81,000 sq ft headquarters includes 67,000 sq ft of warehouse space that is expected to be in use within the next few months. The space … [Read more...] about Renaissance Lakewood opens new headquarters
Bespak and DevPro developing HFO-1234ze albuterol MDI
CDMO Bespak and DevPro Biopharma have revealed their partnership on development of DevPro's DP007 albuterol MDI, which is formulated with Honeywell's Solstice Air HFO-1234ze(E) propellant. According to the companies, DP007 is expected to provide a lower global warming potential alternative to Ventolin HFA MDI. Bespak and DevPro say that they plan to initiate clinical … [Read more...] about Bespak and DevPro developing HFO-1234ze albuterol MDI
Kindeva to add additional LGWP propellant MDI manufacturing line
Kindeva Drug Delivery has announced that it will install a second LGWP propellant MDI manufacturing line at its facility in Loughborough, UK. The company's first LGWP line at Loughborough is expected to be completed by the end of this year. Kindeva The new line, which will fill both HFA-152a and HFO-1234ze(e), is expected to come on line in 2026. In August 2023, … [Read more...] about Kindeva to add additional LGWP propellant MDI manufacturing line
Iconovo’s ICOres DPI gets Chinese patent
According to Iconovo, the Chinese Patent Office has said it will approve the company's application for a patent covering its ICOres reservoir-based dry powder inhaler platform that will provide protection until 2040. The ICOres platform has already received patent protection in the US, Europe, Sweden, India, and Japan, the company said. The dual chamber ICOres … [Read more...] about Iconovo’s ICOres DPI gets Chinese patent
Bespak and H&T Presspart announce partnership on LGWP propellant transition services
Device and component maker H&T Presspart and CDMO Bespak, which recently spun out from Recipharm, have announced that they will collaborate on projects related to low global warming potential (LGWP) propellants. According to the companies, "The collaboration leverages H&T Presspart’s expertise in inhalation product development, the company’s low GWP filling … [Read more...] about Bespak and H&T Presspart announce partnership on LGWP propellant transition services
Nebu-Flow raises $5.9 million for continued development of its SAW nebulization technology
Nebu-Flow announced that it has closed a $5.9 million funding round led by venture capital firm SCVC that will support continued development of the company's surface acoustic wave (SAW) nebulization technology. In 2022, the University of Glasgow spinout announced that it had closed a £1.7 million funding round and received a £1 million grant from Innovate UK. … [Read more...] about Nebu-Flow raises $5.9 million for continued development of its SAW nebulization technology
Adherium’s Hailie Smartinhaler monitor cleared for use with Airsupra and Breztri
According to inhaler monitor company Adherium, the FDA has cleared the Hailie Smartinhaler sensor for use with the Airsupra albuterol / budesonide MDI and with the Breztri Aerosphere budesonide / glycopyrronium / formoterol fumarate MDI, both from AstraZeneca. The Hailie system is already approved for use with a number of different inhalers, including GSK's Ventolin, … [Read more...] about Adherium’s Hailie Smartinhaler monitor cleared for use with Airsupra and Breztri
Lonza now offers spray drying of proteins for inhalation
Lonza has announced that its Center of Excellence for respiratory formulations in Bend, OR, US can now offer kilogram scale spray drying of proteins for inhalation. With the latest expansion, the company is now able to serve customers who need clinical and/or commercial manufacturing for protein DPI formulations. Lonza Director, Respiratory Delivery, Kimberly … [Read more...] about Lonza now offers spray drying of proteins for inhalation